Assessing clinical utility of genomic risk stratification for cancer prevention: a systematic review
Abstract Background Despite advances in genomics for cancer prevention, its clinical utility remains inadequately assessed. This study, conducted within the European Joint Action JANE2, synthesizes evidence on the clinical utility of genomic-based personalized preventive strategies. Methods We conducted a systematic re...